European Companies Search Engine
Registration · Managing Director: Angela Müller · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb15 Jan 2008 German Trade Register Announcements, Germany (10/01/2008)
Overview
Text
HyperCyt GmbH, Polch (
Steiger Str. 24, 56751 Polch
). GmbH. The company's purpose is to develop, validate and implement flow cytometric assays for human immunodiagnosis, advise laboratory physicians and implement analytical tests for diagnostics, training laboratory personnel, evaluation and development of diagnostic and prognostic tests for equine veterinary medicine (focus on immunology), development of cell therapy methods for immunodeficiencies (human/horse). Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Directors: Müller, Angela, Polch, *??.??.????, to enter into legal transactions on behalf of the company with the power to represent each other in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: HyperCyt GmbH, Polch, Germany.
